United Therapeutics Corp (UTHR) Tops Q2 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $513.12 -1.51%
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q2 EPS of $1.49, $0.96 better than the analyst estimate of $0.53. Revenue for the quarter came in at $183.75 million versus the consensus estimate of $180.84 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Therapeutics completes enrollment in PPF lung fibrosis trial
- ScanSource (SCSC) Tops Q4 EPS by 32c
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
